CA

Candid Therapeutics

4 known investors

candidrx.com ↗

CandidRx develops T-cell engager antibodies to treat autoimmune diseases by redirecting T-cells to eliminate autoreactive B-cells. The company focuses on creating therapies that are more effective and easier to administer than existing antibody and cell therapy approaches.

Investors · 4

OR

OrbiMedNew York

TH

Third Rock VenturesBoston

VE

venBio PartnersSan Francisco

VI

Vida VenturesLos Angeles